# IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients

> **NCT03204838** · — · UNKNOWN · sponsor: **Hospital General de Mexico** · enrollment: 100 (estimated)

## Conditions studied

- Acute Myeloid Leukemia (AML)

## Interventions

- **GENETIC:** IDH mutation test performed at diagnosis

## Key facts

- **NCT ID:** NCT03204838
- **Lead sponsor:** Hospital General de Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-10
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-05-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204838, "IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03204838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*